Loading clinical trials...
Loading clinical trials...
Fibrotic interstitial lung diseases (F-ILDs), including both idiopathic pulmonary fibrosis (IPF) and non-IPF, are chronic and progressive lung diseases characterized by excessive scarring of lung tiss...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Eirini Vasarmidi, MD MSc PhD, Ass. Professor
CONTACT
Lead Sponsor
Katerina M. Antoniou
NCT06329401 · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, and more
NCT06238622 · Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
NCT07332117 · Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis
NCT05975983 · Idiopathic Pulmonary Fibrosis (IPF)
NCT06182748 · Fibrotic Interstitial Lungs Diseases
Respiratory Department, University Hospital of Heraklion, School of Medicine, University of Crete
Heraklion, Crete
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions